Functional antagonism of TMPRSS2-ERG splice variants in prostate cancer.
about
Regulation of endothelial homeostasis, vascular development and angiogenesis by the transcription factor ERGMolecular pathological epidemiology in diabetes mellitus and risk of hepatocellular carcinomaNoninvasive Prenatal Diagnosis Significance of ERG Methylation as a Biomarker in Down's SyndromeAutoantibodies against oncogenic ERG protein in prostate cancer: potential use in diagnosis and prognosis in a panel with C-MYC, AMACR and HERV-K Gag.Calcium and Nuclear Signaling in Prostate Cancer.
P2860
Functional antagonism of TMPRSS2-ERG splice variants in prostate cancer.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
Functional antagonism of TMPRSS2-ERG splice variants in prostate cancer.
@ast
Functional antagonism of TMPRSS2-ERG splice variants in prostate cancer.
@en
Functional antagonism of TMPRSS2-ERG splice variants in prostate cancer.
@nl
type
label
Functional antagonism of TMPRSS2-ERG splice variants in prostate cancer.
@ast
Functional antagonism of TMPRSS2-ERG splice variants in prostate cancer.
@en
Functional antagonism of TMPRSS2-ERG splice variants in prostate cancer.
@nl
prefLabel
Functional antagonism of TMPRSS2-ERG splice variants in prostate cancer.
@ast
Functional antagonism of TMPRSS2-ERG splice variants in prostate cancer.
@en
Functional antagonism of TMPRSS2-ERG splice variants in prostate cancer.
@nl
P2093
P2860
P1433
P1476
Functional antagonism of TMPRSS2-ERG splice variants in prostate cancer
@en
P2093
Ahmed A Mohamed
Alagarsamy Srinivasan
Albert Dobi
Anshu Rastogi
David G McLeod
Isabell A Sesterhenn
Jacob Kagan
Shiv Srivastava
Shyh-Han Tan
Sudhir Srivastava
P2860
P304
P356
10.18632/GENESANDCANCER.25
P577
2014-07-01T00:00:00Z